OM1
OM1, Inc. is a Boston-based healthcare technology and data company focused on real-world evidence, personalized medicine, clinical registries, and predictive healthcare AI. Its platform combines deep longitudinal clinical data with artificial intelligence to identify patient phenotypes, accelerate diagnosis and research, estimate treatment effects, predict medical events and outcomes, support regulatory-grade evidence generation, and inform clinical and commercial decision-making. OM1 reports that its PhenOM® healthcare foundation model is trained on more than 1 billion patient-years and that its Real-World Data Cloud covers more than 350 million individuals, using linked electronic medical record, claims, laboratory, specialty-network, social-determinants, and mortality data. Its offerings include PhenOM®, OM1 Aspen for automated study and evidence generation, and products such as Orion, Lyra, and Polaris. The company serves life-sciences, healthcare, research, and government organizations and positions itself as an AI-enabled real-world data and outcomes platform for chronic and specialty conditions.
Company Details
- Website
- om1.com
- Headquarters
- Boston, Massachusetts, United States
- Founded
- 2015
- Funding
- $171M-$176.25M reported across four rounds; the difference reflects varying database methodologies
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring